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Introduction: Aging of the population is an issue of great
public health significance. Forecasts indicate that the
number of Americans 65 years of age and older will
increase from 39 million in 2008 to between 99 million and
108 million by 2050 [1]. The population aged 85 years or
older is projected to rise from 5.4 million in 2008 to
between 25 million and 35 million by 2050 [1]. These
changes will bring new challenges in treating a greater
number of older adults with psychiatric conditions [2].
Especially important will be the recognition, prevention,
and treatment of neurocognitive disorders. Cognitive ability
is a significant predictor of self-rated successful aging [3].
Indeed, cognitive ability is one of the major correlates of
successful aging, along with optimism, resilience, and
physical and mental health–related quality of life [3].
Age-associated cognitive decline that is greater than
expected but without significant functional disability is
designated mild cognitive impairment (MCI). MCI is an
increasingly recognized neuropsychiatric problem in the
aging population that is an important risk factor for
dementia and subsequent institutionalization [4–6]. Despite
these data, no medications are currently available for
treating MCI in the aging population that are approved by
the US Food and Drug Administration [6].
It is reasonable to hypothesize that exercise may be an
important intervention for promoting successful cognitive
aging. Exercise has a documented role in preventing
cellular and molecular changes related to aging [7, 8].
Furthermore, exercise has been shown to improve at least
some aspects of cognition in animal models and in clinical
investigations [9, 10]. Data from the present study suggest
that aerobic exercise may be an effective nonpharmacologic
intervention for preserving healthy cognition and possibly
alleviating disability associated with MCI in late life.
Aims: This study examined the effects of aerobic exercise
on cognition in sedentary older men and women with MCI.
The authors investigated the effects of prolonged high-
intensity aerobic exercise on multiple neuropsychological
measures of cognition. The study also examined the effects
of aerobic exercise on metabolic indices and on putative
biomarkers of Alzheimer’s disease. The authors further
investigated the role of gender in predicting outcome.
Methods: The investigators performed an extensive screen-
ing of 466 adults by telephone. Of the adults screened, 426
were excluded for a variety of reasons, such as declining
participation, not having a history of memory impairment,
not being sedentary, or having a medical condition that
precluded their participation (ie, unstable cardiac disease,
cerebrovascular disease, musculoskeletal impairment, or
other conditions with significant medical sequelae). Seven
individuals were excluded because they withdrew consent,
failed treadmill tests, or experienced vasovagal syncope
with blood draw.
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At enrollment, 33 sedentary adults between the ages of
55 and 85 who were diagnosed with MCI were randomly
assigned to aerobic exercise or a control group. MCI was
diagnosed using Petersen criteria [11]. Participants were
allowed to continue taking β-blockers or statins but not
allowed to take antidiabetes medications. The exercise
intervention consisted of an exercise routine 4 day/week
for 45–60 min/session. Exercise involved a regimen of
gradually increasing intensity until participants achieved
75–85% of their heart rate reserve.
Cognitive tests, metabolic tests, and biomarker assays
were performed at baseline, 3 months, and 6 months.
Cognitive tests included Symbol Digit Modalities, Verbal
Fluency, Stroop, Trails B, Task Switching, Story Recall,
and List Learning. Metabolic parameters included total
body fat, body mass index, cholesterol, lipids, triglycerides,
insulin sensitivity, and cortisol. Biomarkers included brain-
derived neurotrophic factor (BDNF) and β-amyloid protein.
Four individuals (two men and two women) in the aerobic
exercise group discontinued the study before completing
6 months of intervention. These individuals were noted to
have higher fasting baseline plasma glucose levels than
completers but were similar in other baseline measure-
ments. The primary analysis included 10 women and 9 men
in the exercise group and 5 women and 5 men in the
stretching control group.
Results: At enrollment, the exercise and control groups
were similar in mean age, cognitive performance, physical
fitness, and metabolic parameters. At baseline, women were
noted to have higher Mini-Mental State Examination
(MMSE) scores, body fat, cholesterol, and cortisol levels,
and lower insulin-like growth factor 1 levels than men. Six
months of high-intensity exercise improved exercise tread-
mill test assessment of VO2 peak, a measure of maximum
volume of oxygen consumption that reflects physical
fitness. This exercise regimen also improved treadmill
grade and treadmill time to exhaustion relative to stretching
control. Neither gender nor β-blocker use was found to
affect these findings.
After 6 months of high-intensity exercise, a significant
improvement was observed in executive functioning skills of
multitasking, cognitive flexibility, information-processing
efficiency, and selective attention. Further analysis revealed
gender-specific effects on cognition, cortisol, and BDNF. In
women, increasing VO2 peak was associated with improved
executive functioning. Also, in women, high-intensity
exercise resulted in a statistically significant improvement
on Symbol Digit Modalities, Verbal Fluency, and Stroop
tests, and a trend toward improvement on Trails B. Analysis
of these measured at 3 months did not reach statistical
significance, indicating that a prolonged duration of exercise
may be necessary to attain these benefits.
Cognitive improvements were paralleled by statistically
significant increases in insulin sensitivity and decreases in
plasma cortisol and BDNF. In men, high-intensity exercise
resulted in a trend toward improvement on Trails B alone
and a statistically significant increase in plasma cortisol and
BDNF. Men and women demonstrated similar improve-
ments in cardiac fitness and similar decreases in body fat,
cholesterol, and low-density lipoproteins.
Discussion: The authors concluded that aerobic exercise is
an important intervention that may mitigate MCI in older
individuals. The improved performance by women across
multiple neuropsychological domains, as contrasted with a
limited response by men, suggests that aging women may
find aerobic exercise especially beneficial to cognitive
function. The cognitive improvements in women may be
related to exercise-induced alterations in the hypothalamic-
pituitary-adrenal axis, glucose metabolism, and BDNF that
are not seen in men.
Comments
This study had several notable strengths. It used
extensive screening to ensure that the participants
qualified as sedentary older adults with MCI who were
physically fit enough to meet the demands of intensive
exercise. These individuals were then randomly assigned
to an aerobic exercise group or a stretching control
group. The exercise intervention was a well-defined
regimen consisting of an exercise routine 4 day/week
for 45–60 min/session for 6 months. The intensity of the
exercise routine was monitored so that participants were
exercising at 75–80% of heart rate reserve. A reasonably
detailed assessment of neuropsychological functioning and
accompanying physiologic assessments and biomarker assays
were performed at the study’s completion.
However, these encouraging results should be considered
in the context of this study’s limitations. First, it is not clear
how the original 466 adults who were screened were selected.
Information is not provided on what guided the investigators
to contact these individuals and from what population they
were contacted. Furthermore, in their initial screening of 466
adults, 113 were excluded because of a significant medical
condition. Therefore, these findings may have limited
generalizability to real world older adult populations, although
this is understandable in view of the nature of the intervention
(ie, high-intensity aerobic exercise for 6 months). The primary
analysis was based on a small sample of 19 individuals in the
aerobic group and 10 in the control group. Future studies with
a lower intensity exercise regimen may allow for less strict
enrollment screening and allow for a greater sample number
and greater applicability.
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Although the study collected considerable data at
baseline, an even greater detail of baseline data would have
allowed for a more rigorous analysis of treatment and
control group equivalence at enrollment. For instance,
although data are provided on the number of participants
on β-blockers and statins, it is not known which other
medications the individuals were taking during the study
that might have impacted on their cognitive performance.
Although the authors screened and excluded patients with
significant medical sequelae, information on the number of
less severe conditions affecting each treatment group is not
provided. Individuals within this age range may be affected
by many medical conditions that did not warrant exclusion
but whose presentation or treatment may have an effect on
cognitive performance [12, 13].
A greater sample number that included additional
baseline data analysis would also allow for a more
thorough assessment of the gender specificity of the
results reported. For example, while women in the
aerobic exercise group displayed a selective improvement
on many neuropsychological tests, at enrollment, they
were also noted to have higher MMSE scores, body fat,
cholesterol, and cortisol levels, and lower insulin-like
growth factor 1 levels than men. It would be interesting
to examine whether men with comparable baseline
MMSE or metabolic profiles, relative to women counter-
parts, would demonstrate similar improvements in cog-
nition with high-intensity aerobic exercise. These may be
important variables that predict cognitive improvement
with aerobic exercise in aging populations that are
independent of gender.
Future studies examining the neurobiological sub-
strates for the cognitive-enhancing effects of exercise
will also be an exciting new direction. Recent findings
have implicated sestrin and target-of-rapamycin signaling
as important mechanisms in age-related neuropathologies
[14]. To date, few investigations have addressed how
exercise may affect these signaling pathways in the aging
brain. Studies addressing the impact of exercise on these
signaling pathways could provide important basic scien-
tific data to complement the clinical inquiries.
In summary, this is an important study that provides
groundwork for more extensive research. Given the
potential disability associated with cognitive impairment
in older people and limited data on effective interventions,
it provides important preliminary information on the effects
of exercise in MCI.
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